MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$19,704K
Net loss
-$19,630K
Unrealized loss on
investments, net
-$74K
Interest income, net
$803K
Change in fair value of
derivative liability
$480K
Loss before taxes
-$19,618K
Income tax expense
$12K
Total other income,
net
$1,283K
Loss from operations
-$20,901K
Total operating
expenses
$20,901K
Research and development
$14,047K
General and
administrative
$6,854K
Back
Back
Income Statement
source: myfinsight.com
Avalo Therapeutics, Inc. (AVTX)
Avalo Therapeutics, Inc. (AVTX)